RMD Open | Publishes peer-reviewed original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases.

Intro Widget

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR. You can keep up with the latest news via Twitter and Facebook.

Listen to the ARD and RMD Open podcast and subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts and Spotify.

Scopus CiteScore: 3.86 (2018)

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

Authors

RMD Open considers submissions of a variety of article types, including original articles, short reports and clinical cases.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Scopus and Google Scholar.

Author information

Submit a paper

Intro Widget

Authors

Latest Articles

Vasculitis:

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis

Epidemiology:

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases

Autoimmunity:

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

Psoriatic arthritis:

Measurement properties of the minimal disease activity criteria for psoriatic arthritis

Spondyloarthritis:

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

Most Read Articles

Lupus:

Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms

Connective tissue diseases:

Relapsing polychondritis: state of the art on clinical practice guidelines

Connective tissue diseases:

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines

Rheumatoid arthritis:

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment

Treatments:

Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis

Altmetrics

Related Journals